Applied Therapeutics Inc.

16.45+0.1400+0.86%Vol 63.20K1Y Perf -59.62%
Apr 13th, 2021 16:00 DELAYED
BID16.42 ASK16.46
Open16.45 Previous Close16.31
Pre-Market- After-Market-
 - -  - -%
Target Price
60.00 
Analyst Rating
Strong Buy 1.00
Potential %
264.74 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-89/-94/-98 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-13/-64/-98 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-13/-65/-97 
Income Ranking
 —    -
Market Cap427.85M 
Earnings Rating
Buy
Price Range Ratio 52W %
7.47 
Earnings Date
10th May 2021

Today's Price Range

16.2216.82

52W Range

13.5851.99

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.55%
1 Month
-15.51%
3 Months
-24.51%
6 Months
-30.59%
1 Year
-59.62%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
APLT16.450.14000.86
AAPL134.433.19002.43
GOOG2 267.2712.48000.55
MSFT258.312.40000.94
XOM55.710.21000.38
WFC39.79-0.9800-2.40
JNJ159.48-2.1600-1.34
FB309.76-1.7800-0.57
GE13.44-0.1500-1.10
JPM154.09-1.8600-1.19
Earnings HistoryEstimateReportedSurprise %
Q04 2020-1.31-1.0619.08
Q03 2020-1.04-1.33-27.88
Q02 2020-0.72-1.27-76.39
Q01 2020-0.75-0.5921.33
Q04 2019-0.63-1.57-149.21
Q03 2019-0.37-0.63-70.27
Q02 2019-0.39-0.60-53.85
Q01 2019-0.39-1.58-305.13
Earnings Per EndEstimateRevision %Trend
3/2021 QR-1.060.93Positive
6/2021 QR-1.090.91Positive
12/2021 FY-4.82-11.06Negative
12/2022 FY-4.12-45.07Negative
Next Report Date10th May 2021
Estimated EPS Next Report-1.06
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume63.20K
Shares Outstanding26.01M
Trades Count959
Dollar Volume2.43M
Avg. Volume128.94K
Avg. Weekly Volume89.80K
Avg. Monthly Volume104.87K
Avg. Quarterly Volume134.79K

Applied Therapeutics Inc. (NASDAQ: APLT) stock closed at 16.45 per share at the end of the most recent trading day (a 0.86% change compared to the prior day closing price) with a volume of 63.20K shares and market capitalization of 427.85M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 22 people. Applied Therapeutics Inc. CEO is Shoshana Shendelman.

The one-year performance of Applied Therapeutics Inc. stock is -59.62%, while year-to-date (YTD) performance is -25.26%. APLT stock has a five-year performance of %. Its 52-week range is between 13.58 and 51.99, which gives APLT stock a 52-week price range ratio of 7.47%

Applied Therapeutics Inc. currently has a PE ratio of -4.00, a price-to-book (PB) ratio of 5.37, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -119.55%, a ROC of -124.22% and a ROE of -160.02%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Applied Therapeutics Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-1.06 for the next earnings report. Applied Therapeutics Inc.’s next earnings report date is 10th May 2021.

The consensus rating of Wall Street analysts for Applied Therapeutics Inc. is Strong Buy (1), with a target price of $60, which is +264.74% compared to the current price. The earnings rating for Applied Therapeutics Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Applied Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Applied Therapeutics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 14.99, ATR14 : 2.05, CCI20 : -108.77, Chaikin Money Flow : -0.29, MACD : -1.79, Money Flow Index : 32.00, ROC : -18.60, RSI : 33.97, STOCH (14,3) : 7.94, STOCH RSI : 0.54, UO : 38.06, Williams %R : -92.06), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Applied Therapeutics Inc. in the last 12-months were: Joel S. Marcus (Sold 40 000 shares of value $1 780 300 ), Les Funtleyder (Option Excercise at a value of $321 076), Les Funtleyder (Sold 219 062 shares of value $8 652 370 ), Riccardo Perfetti (Option Excercise at a value of $45 252), Riccardo Perfetti (Sold 30 495 shares of value $688 292 ), Shoshana Shendelman (Option Excercise at a value of $297 445), Shoshana Shendelman (Sold 215 000 shares of value $7 972 085 ), Stacy J. Kanter (Buy at a value of $148 590)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.

CEO: Shoshana Shendelman

Telephone: +1 212 220-9226

Address: 545 Fifth Avenue, New York 10173, NY, US

Number of employees: 22

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

58%42%

Bearish Bullish

58%42%

News

Stocktwits